Table 5.

Five-Year Major Adverse Clinical Events in Patients With and Without m-SVGs in the Angiographic Cohort: All Events (Including Those Before, During, and After Protocol Angiography)

		m-SVGs		Unadjusted		Adjusted*
Clinical Events		Yes (n = 826)	No (n = 1574)	HR (95% CI)	P	HR (95% CI)	P
Death, MIs or revascularizations, n		300	481	1.24 (1.07, 1.43)	0.004	1.20 (1.03, 1.39)	0.018
5-y event rate, %	5-y event rate	36.7	31.0
Deaths or MI, n	# of events	215	318	1.32 (1.11, 1.57)	0.002	1.27 (1.06, 1.52)	0.011
5-y event rate, %	5-y event rate	26.3	20.5
Death or revascularization, n	# of events	226	370	1.19 (1.01, 1.40)	.0043	1.16 (0.97, 1.38)	0.098
5-y event rate, %	5-y event rate	27.8	23.9
All death, n	# of events	108	165	1.25 (0.98, 1.60)	0.070	1.21 (0.94, 1.56)	0.140
5-y event rate, %	5-y event rate	13.4	10.7

^*Adjusted for age, sex, race, history of congestive heart failure, creatinine clearance, recent MI (within 30 d of enrollment), weight, height, diastolic blood pressure, on-pump surgery, length of surgery, harvesting technique, and use of internal mammary artery conduit.

m-SVG indicates saphenous vein graft with >1 distal target; HR, hazard ratio; CI, confidence interval; and MI, myocardial infarction.